GPER1 and cervical carcinoma: However, we are aware that to determine the effects of GPER1 in the activation of different oncogenes in cervical cancer, it would be necessary to carry out complementary studies about the mechanisms of action of the 17β-AEs, both alone and in combination with different inhibitors of GPER1, in the signaling pathways involved in transactivation with GPER1.